Mode
Text Size
Log in / Sign up
N/A N=22 Randomized Triple-blind Treatment

Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients

Alzheimer's Disease

Enrolled (actual)
22
Serious AEs
4.6%
Results posted
Jun 2017
Primary outcome: Primary: Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) — 1.79; -0.20; -0.66 percentage change

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Repetitive Transcranial Magnetic Stimulation (rTMS) (Device); NICE Cognitive Training (Behavioral)
Age
Adult, Older Adult · 55+ yrs
Sex
All
Sponsor
Beth Israel Deaconess Medical Center
Primary completion
May 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog)
1.79; -0.20; -0.66
SECONDARY
Clinical Global Impression of Change (CGIC)
3.25; 4.40; 4.08
SECONDARY
Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL)
72.67; 73.60; 65.75; 69.78; 71.20; 61.75

Summary

This study looks at the potential benefits of combining cognitive training (mental exercises) together with transcranial magnetic stimulation (also known as TMS) to see if this can make a difference in the condition of people with Alzheimer's disease by improving their disease and the cognitive decline that goes along with it.

Eligibility Criteria

Inclusion Criteria

  • Male or female age 55-90
  • Diagnosed with mild to moderate AD according to DSM-IV criteria
  • Diagnosis of dementia of the Alzheimer's type according to the criteria established by the NINCDS-ADRDA
  • Normal or corrected normal ability to see and hear
  • Primary language is English

Exclusion Criteria

  • IQ below 85
  • Any major structural abnormalities on MRI (eg. Infarction, intracerebral malformation)
  • Any symptoms of disease or abnormalities sufficient to cause memory impairment other than AD (eg. Normal pressure hydrocephalus, progressive supranuclear palsy)
  • Any functional psychiatric disorder (eg. Schizophrenia)
  • Chronic uncontrolled medical conditions that may cause a medical emergency in case of a provoked seizure (eg. Cardiac malformation)
  • History of seizures, diagnosis of epilepsy
  • Metal implants excluding dental fillings or any of the following medical devices: pacemaker, implanted medication pump, vagal nerve stimulator, deep brain stimulator, TENS unit (unless removed completely for this study), cerebral spinal fluid shunt
  • Recent withdrawal from the following drugs: alcohol, barbiturates, benzodiazepines, meprobamate, chloral hydrate
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01504958). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search